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Abstract
Type IV secretion systems (T4SS) are used by Gram-negative bacteria to translocate protein and DNA substrates across the
cell envelope and into target cells. Translocation across the outer membrane is achieved via a ringed tetradecameric outer
membrane complex made up of a small VirB7 lipoprotein (normally 30 to 45 residues in the mature form) and the C-terminal
domains of the VirB9 and VirB10 subunits. Several species from the genera of Xanthomonas phytopathogens possess an
uncharacterized type IV secretion system with some distinguishing features, one of which is an unusually large VirB7
subunit (118 residues in the mature form). Here, we report the NMR and 1.0 A ˚ X-ray structures of the VirB7 subunit from
Xanthomonas citri subsp. citri (VirB7XAC2622) and its interaction with VirB9. NMR solution studies show that residues 27–41 of
the disordered flexible N-terminal region of VirB7XAC2622 interact specifically with the VirB9 C-terminal domain, resulting in a
significant reduction in the conformational freedom of both regions. VirB7XAC2622 has a unique C-terminal domain whose
topology is strikingly similar to that of N0 domains found in proteins from different systems involved in transport across the
bacterial outer membrane. We show that VirB7XAC2622 oligomerizes through interactions involving conserved residues in the
N0 domain and residues 42–49 within the flexible N-terminal region and that these homotropic interactions can persist in
the presence of heterotropic interactions with VirB9. Finally, we propose that VirB7XAC2622 oligomerization is compatible
with the core complex structure in a manner such that the N0 domains form an extra layer on the perimeter of the
tetradecameric ring.
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Introduction
Bacteria employ multiprotein secretion systems to translocate
effector proteins or nucleoprotein complexes across the cell
envelope where they modulate the bacterium’s interactions with
the environment. In Gram-negative bacteria, the secretion systems
have been classified into 6 different types [1,2]. The type IV
secretion systems (T4SSs) are ancestrally related to bacterial
conjugation machines [3] and are able to translocate proteins
and/or protein-DNA complexes to the extracellular milieu or the
host interior, in many cases contributing to the ability of the
bacterial pathogen to colonize the host and evade its immune
system [4]. T4SSs are important in the pathogenic mechanism of
many microbes, including the animal pathogens Legionella
pneumophila (Legionnaires’ disease; [5]), Bordetella pertussis (whooping
cough; [6]), Coxiella burnetii (Q fever; [7]), Bartonella henselae (cat
scratch disease, [8]), Brucella spp. (brucellosis; [9]) and Helicobacter
pylori (gastritis, ulcers, stomach cancer; [10]), as well as the plant
pathogen Agrobacterium tumefaciens (crown gall disease; [11]) which
has the prototype T4SS, composed of 12 proteins, VirB1-VirB11
and VirD4 [12].
Xanthomonas citri subsp. citri (formerly Xanthomonas axonopodis pv.
citri) (Xac) is a gammaproteobacterial phytopathogen which
causes citrus canker, a disease that affects all citrus plants and
has significant economic impact worldwide [13]. The Xac genome
was sequenced and many potential virulence-related genes were
identified [14], including an 18 kb chromosomal vir locus that
codes for a T4SS [13,14,15]. Orthologous T4SSs have been
identified in the closely related species Xanthomonas campestris pv.
campestris (strains ATCC 33913 [14], 8004 [16] and B100 [17]),
Xanthomonas albilineans [18], Xanthomonas campestris pv. vasculorum
NCPPB702 [19], Xanthomonas campestris pv. musacearum
NCPPB4381 [19] and Stenotrophomonas maltophilia (strains K279A
[20] and R551-3 [21]). The vir locus is incomplete in Xanthomonas
campestris pv. vesicatoria [22] and is absent in four Xanthomonas
oryzae strains (KACC10331 [23], MAFF311018 [24], PXO99A
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two Xanthomonas fuscans subsp. aurantifolii lineages (10535 and
11122 [26]). The unrelated Gram-negative bacteria Neisseria
flavescens SK114 (GenBank database ACQV00000000) and
Neisseria sp. oral taxon 014 str. F0314 (GenBank database
ADEA00000000) also present a locus highly similar to the T4SS
loci found in the Xanthomonadaceae family. Some Xanthomonas
genomes, including Xac, carry megaplasmids that code for a
second T4SS probably involved in plasmid mobilization and
whose structural components exhibit only very low sequence
identity to their counterparts in the chromosomally encoded T4SS
under study [15,27].
One particularly distinctive feature of the Xanthomonad T4SSs
is related to the VirB7 component. In well-characterized T4SSs,
VirB7 is a lipoprotein attached to the periplasmic side of the outer
membrane [28]. It has been shown to interact with several T4SS
subunits [29], including itself [30] and the VirB9 C-terminal
region [31,32]. The structure of a VirB7-VirB9-VirB10 complex
(TraN-TraO-TraF) from the T4SS of the conjugative plasmid
pKM101 demonstrated that these proteins form a hetero-
tetradecameric outer membrane channel through which the
substrates pass [33,34]. Structures of the complex formed between
the TraO C-terminal domain and TraN revealed that the 33-
residue TraN forms an extended structure that winds around the
TraO b-sandwich [34,35].
Members of the VirB7 family are typically 45–65 residues long
[36], becoming 15–20 residues shorter after removal of the N-
terminal signal sequence and covalent attachment to lipid molecules.
In Xac, several lines of evidence indicate that the gene xac2622 codes
for a VirB7 equivalent; specifically, the gene position, the presence of
signals for outer membrane localization and lipidation and the
interaction of its product with VirB9 [15]. However, XAC2622 does
not exhibit any sequence similarity with the VirB7 family and it is
much larger than a typical VirB7 protein (139 and 118 residues
before and after signal sequence removal, respectively).
In order to understand the unique structural features of
Xanthomonad VirB7, we have solved the solution nuclear
magnetic resonance (NMR) and X-ray crystal structures of
XAC2622, which we now call VirB7XAC2622, and studied its
interaction with VirB9. VirB7XAC2622 presents all of the
characteristics of VirB7: predicted signal peptide and lipobox
sequences followed by a short and extended region that contains
the VirB9 binding site. However, unlike other VirB7 proteins,
VirB7XAC2622 has an extra domain whose topology is strikingly
similar to that of N0 domains found in proteins from different
multi-subunit complexes involved in transport across the bacterial
outer membrane. We show that VirB7XAC2622 oligomerizes
through interactions involving conserved residues in the folded
domain and the unfolded N-terminus and that oligomerization
and the formation of the VirB7XAC2622-VirB9 complex can occur
simultaneously. We propose that these interactions are compatible
with the tetradecameric core complex structure, resulting in the
formation of an extra ring layer.
Results
Solution Structure of Xac VirB7 (VirB7XAC2622_24–139)
The construct used for NMR structure determination corre-
sponds to residues 24–139 of VirB7XAC2622 preceded by a Gly-
Ser-His-Met sequence. Bioinformatics analysis predicts that
residues 1–21 would be removed and Cys22 lipidated, leading to
anchoring in the bacterial outer membrane [15]. Approximately
98% of main chain and aliphatic side chain and 93% of aromatic
side chain
1H,
13C and
15N resonances were assigned (Table 1 and
Figure S1). A total of 2176 experimental NMR restraints,
consisting of 2056 interproton distances and 120 torsion angles,
were used in the structure calculation (Table 1). A small set of
nuclear Overhauser effect (NOE) cross-peaks that were not
assigned by CYANA [37] were subsequently identified as resulting
from intermolecular contacts (see below).
The solution structure of VirB7XAC2622_24–139 consists of a
globular domain (residues 52–133), flanked by a long disordered
N-terminus (amino acids 24–51) and a short flexible C-terminus
(residues 134–139) (Figure 1A). The globular domain is composed
of two a-helices sandwiched between a mixed three stranded b-
sheet on one side and an antiparallel two-stranded b-sheet plus a
short 310 helix on the other (Figure 1B). The NMR structures were
independently validated by
1H-
15N residual dipolar couplings
(RDCs). The average Q factor obtained by fitting RDCs from
secondary structure elements to the whole NMR ensemble is
0.27160.019, consistent with a good quality structure [38,39,40].
High Resolution X-ray Crystal Structure of the
VirB7XAC2622 Globular Domain
To better characterize the globular domain, we cloned and
purified a recombinant fragment encompassing residues 51–134
(VirB7XAC2622_51–134) which was submitted to crystallization trials
that resulted in large plates (Figure S2) which belong to space
group C2221 and diffracted up to 1.0 A ˚. Molecular replacement
was performed using the solution structure of the VirB7XAC2622
globular domain as the search model. Details of the data collection
and structure refinement are listed in Table 2 and the model is
presented in Figure 1C. There was clear electron density for all
residues, with the exception of the first amino acid (threonine 51)
and residues 122 and 123 in the loop between b4 and b5. As
expected, the crystal structure is very similar to the NMR
ensemble (Figure 1D), displaying an average root mean square
deviation (RMSD) for the backbone heavy atoms and all heavy
atoms of 1.0560.05 A ˚ and 1.6160.06 A ˚ for residues 53–130, and
Author Summary
Many aspects of bacterial life require that they translocate
proteins to the cell exterior. To do this, different
macromolecular secretion systems of varying complexity
have evolved (Type I–VI secretion systems). These secre-
tion systems are often at the front lines of pathogen-host
interactions and are important for the development of
disease. In this work, we have determined the structure
and studied the interactions of an unusually large VirB7
subunit (VirB7XAC2622) of the outer membrane pore of the
Type IV secretion system found in the Xanthomonas
genera of phytopathogens. Its mosaic structure combines
a canonical VirB7 N-terminal region with a C-terminal
globular domain whose topology is observed in a
relatively limited set of proteins, all involved in molecular
transport across outer membranes. Our results lead to the
hypothesis that the VirB7XAC2622 globular domains can
form an extra ring around the perimeter of the outer
membrane pore and reveal deeper structural and evolu-
tionary relationships among bacterial macromolecular
secretion systems that have evolved to adopt a variety
of functions, including structural modules in outer
membrane pores (secretins from Type II, III and IV
secretion systems, Type IV pili and filamentous phages),
signal-transduction modules in TonB-dependent receptors
and membrane-penetrating devices in T6SS and long-
tailed bacteriophages.
Xanthomonas VirB7 Structure and Interactions
PLoS Pathogens | www.plospathogens.org 2 May 2011 | Volume 7 | Issue 5 | e1002031excellent agreement with the backbone
1H-
15N RDCs [Q factor of
0.187 (regular secondary structures only) and 0.272 (all residues)].
VirB7 Oligomerization
Changes in
15N heteronuclear single-quantum coherence (
15N-
HSQC) cross-peak positions as a function of protein concentration
indicated that VirB7XAC2622 oligomerizes in fast exchange on the
NMR time scale (Figure 2A). Consistent with this observation,
alterations in
15NT 1 and T2 relaxation times indicated that the
overall tumbling slows significantly at higher protein concentra-
tions (see below). Chemical shift perturbation data showed that
two regions are involved in VirB7XAC2622 self-interactions: a
region in the unfolded N-terminus (residues 42–49) and a patch on
the surface of the globular domain made up of residues 63–65, 85–
93, 111–119 and 131 (Figure 2B and C).
Two possible interaction schemes can be envisaged that would
be compatible with the chemical shift perturbation data: i) a side-
by-side arrangement in which the N-terminal unfolded segment
and the globular domain of one molecule interact, respectively,
with the same regions of a second molecule, or ii) a head-to-tail
complex arrangement where the N-terminus of one molecule
recognizes the folded domain of the other. In order to test the
hypothesis of the formation of a head to tail complex, we
performed a titration of the
15N-VirB7XAC2622_51–134 globular
domain with an unlabeled peptide encompassing residues 38–52
from the N-terminal region (VirB7XAC2622_38–52). During the
titration, we observed changes in the same cross-peaks which were
perturbed in the entire protein in a concentration dependent
manner (Figure S3). This hypothesis was corroborated by the
analysis of a set of 13 NOEs not assigned by CYANA [37], which
showed that they could be accounted for by the formation of head-
to-tail dimers. Indeed, those NOEs were observed between proton
pairs derived from amino acids whose main-chain
1H-
15N
chemical shifts are perturbed in a concentration dependent
manner (the NOEs are listed in the Materials and Methods).
We then used the set of 13 intermolecular NOEs as geometric
restraints to drive computational docking simulations of the
VirB7XAC2622 dimer using HADDOCK2.0 [41]. In one simula-
tion, a fragment corresponding to the disordered N-terminal
region (residues 24–50) was docked with a fragment corresponding
to the globular domain (residues 51–139) while the second
simulation involved the docking between two full length proteins
(residues 24–139). The resulting models from both simulations
were highly similar. In the second simulation three of the thirteen
NOEs were violated in all solutions by approximately 1.4 to 3 A ˚.
They correspond to weak peaks and could have contributions of
spin diffusion or chemical exchange. These docking simulations
were therefore able to determine the general nature of the
oligomerization interface whose resolution is necessarily limited by
the small number of restraints and by the absence of structural
information for the N-terminal region. One cluster of docking
solutions using full length VirB7XAC2622 is shown in Figure 2D.
To investigate whether VirB7XAC2622_24–139 forms dimers or
higher-order oligomers, glutaraldehyde cross-linking experiments
were performed. These assays showed that VirB7XAC2622_24–139
forms dimers, trimers and higher order oligomers (Figure S4A).
When the cross-linking experiment was performed in the
presence of 1% SDS, no covalently cross-linked oligomers were
observed, indicating that oligomerization requires the presence of
a correctly folded protein (Figure S4A). As expected, no cross-
links were observed when the experiment was performed using
VirB7XAC2622_51–134 which lacks the disordered N-terminal
region (Figure S4B).
VirB7XAC2622 Interaction with VirB9XAC2620
To analyze this interaction, VirB7XAC2622_24–139_His was titrated
into a solution of VirB9XAC2620_34–255 (full-length VirB9XAC2620
minus the first 33 residues including a predicted signal peptide)
and changes in intrinsic fluorescence were monitored. A
monotonic increase in fluorescence emission was detected until
saturation at a 1:1 VirB7:VirB9 stoichiometry (Figure S5). A
dissociation constant of 4610
28 M for the complex was estimated
by fitting the observed fluorescence changes to a binding isotherm
(equation 2, Materials and Methods).
To study this interaction by NMR, the
15N-HSQC spectrum of
15N-VirB7XAC2622_24–139 was acquired in the presence of
Table 1. Assignment and structural statistics for the solution
structure of VirB7XAC2622_24–139.
Completeness of resonance assignments (%)
a 97.6
Backbone 98.4
Side chain 97.6
Aromatic 93.5
Total unambiguous distance constraints 2056
Intra-residue (i=j) 438
Sequential (|i2j|=1) 573
Medium range (1,|i2j|,5) 382
Long range (|i2j|$5) 663
Total dihedral angle constraints 120
Phi/Psi 60/60
Average CYANA target function value (A ˚2) 0.7360.10
Residue constraints violations
NOE violations/structure (.0.3 A ˚) 0.0560.022
NOE violations/structure (.0.5 A ˚)0
RMSD from experimental distance restraints (A ˚) 0.01360.001
Dihedral angle violations/structure (.5 deg.) 0.4060.58
RMSD from experimental dihedral restraints (deg.) 0.6460.11
RMSD from ideal geometry
Bond lengths (A ˚) 0.003260.0001
Bond angles (deg.) 0.39860.008
Improper angles (deg.) 0.35760.014
Average pairwise RMSD (A ˚)
b
Backbone atoms 0.4760.10
Heavy atoms 0.9260.09
Ramachandran plot statistics (%)
Most favored regions 84.9
Additional allowed regions 14.9
Generously allowed 0.0
Disallowed regions 0.2
c
Residual dipolar couplings
d
1H-
15N3 5
Average Q factor with respect to solution structure 0.27160.019
Q factor with respect to crystal structure 0.187
aThe GSHM coded by the N-terminal tag was removed for the analysis
performed by the AVS program [89].
bRMSD calculated for residues 52–133.
cResidue A27 in two structures, K25 and A123 in one conformer (all in different
conformers).
dRDCs were not used in the structure calculation.
doi:10.1371/journal.ppat.1002031.t001
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cross peaks were detected, except for those derived from the
flexible N- and C-terminal residues (amino acids 24–25 and 134–
139; data not shown). This observation is consistent with the
formation of a tight complex with long correlation time, with the
majority of cross peaks beyond detection.
VirB7XAC2622 was previously shown to interact with the C-
terminal domain of VirB9XAC2620 [15] as has been shown for
other VirB7-VirB9 homologs [32,35]. We therefore produced a
fragment, VirB9XAC2620_154–255, corresponding to the C-terminal
domain of VirB9XAC2620. Changes in the
15N-HSQC spectrum of
VirB7XAC2622_24–139 upon adding VirB9XAC2620_154–255 showed
that the binding occurs in slow exchange on the NMR time scale,
consistent with the sub-micromolar affinity detected by fluores-
cence spectroscopy for the interaction with full length VirB9
(VirB9XAC2620_34–255). In order to map the VirB9 binding site on
the structure of VirB7, we assigned the backbone resonances of
VirB7XAC2622_24–139 in complex with VirB9XAC2620_154–255 and
analyzed the chemical shift differences (Figure 3A and B). This
analysis showed that only residues 27–41, within the disordered
VirB7 N-terminus, undergo significant chemical shift perturba-
tions (Figure 3C and D). This region is adjacent to, but does not
overlap, the N-terminal region involved in VirB7XAC2622 oligo-
merization (residues 42–49).
1H-
15N RDCs and backbone
chemical shifts for VirB7XAC2622_24–139 alone and in the presence
of VirB9XAC2620_154–255 are essentially identical, with the excep-
tion of the N-terminal region that is involved in binding to VirB9
(Figure 3 and Figure S6). Thus, the folded domain does not
participate in the recognition of the VirB9XAC2620 C-terminal
domain and the linker between the VirB9 interaction site and the
VirB7 globular domain is flexible enough to permit the two
regions to align independently in the alignment medium.
Interestingly, VirB7XAC2622_24–139 is able to simultaneously
oligomerize and interact with VirB9XAC2620_154–255, as the cross-
peaks related to the regions involved in VirB7 oligomerization shift
even in the presence of VirB9XAC2620_154–255 (Figure S7).
VirB7XAC2622-Induced Changes in the VirB9XAC2620
C-terminal Domain
The
15N-HSQC spectrum of VirB9XAC2620_154–255 showed
characteristics of poor line shape and chemical shift dispersion
(Figure 4; red) suggestive of conformational disorder and a
probable lack of stable tertiary structure. However, when un-
labeled VirB7XAC2622_24–139 was added to the solution containing
Figure 1. NMR and X-ray models of VirB7XAC2622. Superposition of 20 lowest energy VirB7XAC2622_24–139 solution structures: (A) backbone traces
of the full-length protein (residues 24–139) and (B) ribbon representation of the folded domain (residues 51–134) in the NMR ensemble. (C) Ribbon
representation of the X-ray crystal structure of VirB7XAC2622_51–134. Water molecules and one isopropanol ligand are depicted. (D) Superposition of the
X-ray (green) and NMR (lowest energy model; red) structures of the VirB7XAC2622 globular domain.
doi:10.1371/journal.ppat.1002031.g001
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1H-
15N cross peaks became more
uniform in shape and more highly resolved (Figure 4; green).
These observations suggest that VirB9XAC2620_154–255 on its own is
in a dynamic conformational equilibrium or not properly folded in
the absence of VirB7XAC2622_24–139. Nevertheless, it undergoes a
significant conformational change which greatly reduces its
conformational flexibility when bound to the latter protein.
In order to further investigate whether the interaction of
VirB9XAC2620_154–255 with the N-terminal domain of VirB7XAC2622
alone is sufficient to drive the formation of a specific VirB7-VirB9
complex, we studied the interaction of
15N-labeled VirB9 with an
unlabeled peptide derived from the VirB7XAC2622 N-terminus
(residues 24–46), which includes the VirB7XAC2622 N-terminal
segment that interacts with VirB9XAC2620 (amino acids 27–41).
Indeed, the perturbations observed in the
15N-HSQC spectra
of VirB9XAC2620_154–255 in the presence of the full-length
VirB7XAC2622_24–139 or the VirB7XAC2622_24–46 peptide are essen-
tiallythe same (Figure4 and Figure S8),demonstrating thattheVirB7
N-terminal region is sufficient to interact with the VirB9XAC2620 C-
terminal domain.
To investigate whether aggregation could be responsible for the
line broadening observed in the
15N-HSQC spectrum of VirB9 C-
terminal domain, we calculated the approximate overall rotational
correlation time (tc) from estimates of
15NT 1 and T2 obtained
using 1D versions of the
15N relaxation experiments. The values of
tc of VirB9XAC2610_154–255 alone or in complex with the
VirB7XAC2622_24–46 peptide are approximately 6.5 ns (data not
shown), which suggest that the VirB9XAC2620 C-terminal domain
is monomeric in both conditions.
Relaxation Studies of VirB7XAC2622_24–139
Measurements of
15N relaxation times (T1 and T2) and
heteronuclear {
1H}-
15N NOE were performed for
15N-
VirB7XAC2622_24–139 alone (at 100 and 800 mM) and in complex
with unlabeled VirB9XAC2620_154–255. The relaxation data are
consistent with the presence of a flexible N-terminal tail and a
more rigid globular domain (Figure 5). It is worth noting that the
VirB9 binding surface of VirB7XAC2622_24–139 (residues 27–41)
becomes less flexible upon binding to VirB9 (Figure 5A and C). In
the absence of VirB9, residues 29–42 display {
1H}-
15N hetero-
nuclear NOE values close to zero, indicating that this segment is
not fully flexible and may present transient structures poised to
interact with VirB9. Changes in
15N-T1 and
15N-T2 observed
upon raising the VirB7XAC2622_24–139 concentration from 100 to
800 mM indicate a significant decrease in the overall rotational
correlation rate, consistent with the formation of oligomers
(Figure 5B and C). Relaxation parameters for residues involved
in oligomerization (43–47 and some between positions 86 and 93)
were not obtained because they were not detectable in the
15N-
HSQC spectrum at high protein concentration (800 mM).
Although these cross peaks become visible upon diluting the
sample, they display too low amplitude to allow precise measure-
ments. From the
15NT 1 and T2 data, the overall rotational
correlation times of VirB7XAC2622 at the concentrations of 100 and
800 mM were estimated to be 5.8 and 12.6 ns, respectively. These
values are consistent with the predominance of a monomer at lower
concentration and a dimer at higher concentration. This observa-
tion, however, does not exclude the possibility of the existence of an
equilibrium which includes higher-order oligomers, as shown by
glutaraldehyde cross-linking data.
VirB7XAC2622 Contributes to VirB9XAC2620 and
VirB10XAC2619 Stability in vivo
In Agrobacterium tumefaciens cells, the VirB7 protein contributes to
VirB9 and VirB10 stability [42]. We therefore produced a xac2622
gene knockout strain and performed immunoblot experiments to
assess the expression of VirB7XAC2622, VirB9XAC2620 and VirB10-
XAC2619. The production of all three proteins could be detected in
wild type cellsbutnonecould bedetectedintheDvirB7XAC2622strain
(Figure 6A). To evaluate if the absence of VirB9XAC2620 and
VirB10XAC2619 in the mutant strain is due to the lack of the
VirB7XAC2622 production or to a polar effect in the T4SS operon,
DvirB7XAC2622cellswerecomplementedwitha plasmid encodingthe
VirB7XAC2622 protein in trans. The expression of VirB7XAC2622
from the pUFR-VirB7 plasmid restored VirB9XAC2620 and
VirB10XAC2619 protein levels (Figure 6A). Furthermore, no
significant differences in virB9XAC2620 transcript levels were detected
between the wild-type, DvirB7XAC2622 and DvirB7XAC2622+pUFR-
VirB7 strains in quantitative RT-PCR experiments (data not
Table 2. Crystallographic data collection and refinement
statistics of VirB7XAC2622_51–134.
Data Collection
Wavelength (A ˚) 0.9537
Space group C2221
Cell axis a, b, c (A ˚) 27.76, 55.81, 83.10
Resolution (A ˚) 30.00 – 1.04 (1.08 – 1.04)
a
No. of observations 367270
Unique reflections 30386
Rmerge
b 0.068 (0.293)
a
ÆI/s(I)æ 34.8 (5.1)
a
Completeness (%) 96.3 (79.0)
a
Redundancy 12.1 (8.9)
a
Refinement Statistics
Protein molecules per ASU 1
Amino acid residues per ASU 84
Total non-hydrogen atoms 738
Protein atoms 619
Water molecules 115
Ligand atoms 4
Rwork/Rfree
c 0.130/0.152 (0.191/0.209)
a
Figure of Merit 0.92
Average B-factor (A ˚2)
Protein all atoms 10.4
Protein main chain 7.8
Protein side chain 12.6
Water 23.6
Ligand 17.2
RMSD bond lengths (A ˚) 0.013
RMSD bond angles (deg.) 1.690
Ramachandran plot statistics (%)
Most favored regions 95.1
Additionally allowed regions 4.9
aNumbers in parentheses represent data for the highest resolution shell.
bRmerge=Shkl Si |Ii(hkl)2ÆI(hkl)æ |/Shkl SiIi(hkl).
cRwork=S|Fobs2Fcalc|/SFobs.T h eRfree value is the same as Rwork but calculated
on 5% of the data not included in the refinement. ASU, asymmetric unit.
doi:10.1371/journal.ppat.1002031.t002
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PLoS Pathogens | www.plospathogens.org 5 May 2011 | Volume 7 | Issue 5 | e1002031Figure 2. VirB7XAC2622_ _24–139 oligomerization. (A) Superposition of
15N-HSQC spectra of
15N-VirB7XAC2622_24–139 at different concentrations.
Cyan: 850 mM; blue: 600 mM; green: 400 mM; yellow: 300 mM; orange: 200 mM; pink: 100 mM; red: 50 mM; purple: 25 mM; brown: 13 mM and black:
7 mM. The inserts are amplifications of selected spectral regions showing peak movements as the protein concentration varies from 850 to 7 mMi n
the direction of the arrows. (B) Weighted chemical shift changes (Ddcomp) observed upon dilution from 100 mMt o7mM. (C) Surface representation
of VirB7XAC2622_24–139 colored according to the weighted chemical shift changes. Residues involved in oligomerization are located in the folded
domain and in the unfolded N-terminus.
1H-
15N correlation of Leucine 89 (L89) was not detected in any
15N-HSQC spectrum probably due to chemical
exchange. (D) Ribbon representations of docking models of the VirB7XAC2622 – VirB7XAC2622 interaction. Helices, b-strands and coil regions are colored
red, yellow and green, respectively. Residues involved in intermolecular NOEs are shown as stick models colored brown (residues A43, T45, E46, I47,
L49) and green (T63, S85, D86, Y87, T88, I90). Six models are shown.
doi:10.1371/journal.ppat.1002031.g002
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stability of VirB9XAC2620 and VirB10XAC2619 proteins in vivo.
The VirB7, VirB9 and VirB10 orthologs TraN, TraO and TraF
form a stable trimeric complex [33,34]. In order to determine
whether the VirB7XAC2622, VirB9XAC2620 and VirB10XAC2619 form
a stable complex in Xac cells, we performed immunoprecipitation
experiments using antisera for each of the three proteins. Results
described in Figure 6B show that VirB7XAC2622, VirB9XAC2620 and
VirB10XAC2619 are present in the material immunoprecipitated by
each of the three antisera in wild-type cells. Furthermore, none of
the three proteins were immunoprecipitated from DvirB7XAC2622
cells while all three proteins were detected in immunoprecipitation
experimentsusingDvirB7XAC2622+pUFR-VirB7cells(Figure6B).Al-
together, these results show that a complex between VirB7XAC2622,
VirB9XAC2620 and VirB10XAC2619 is formed in vivo in Xac cells.
In order to test the role of VirB7XAC2622 in Xac virulence, sweet
orange leaves were infiltrated with the wild type and DvirB7XAC2622
strains. Both strains presented essentially the same infection
phenotypes, including water-soaking, hyperplasia and necrosis
(Figure 6C) [13]. In planta growth curves of the wild type and
DvirB7XAC2622 cells revealed that the two strains replicate at a
similar rate (Figure 6D). These data indicate that the VirB7XAC2622
Figure 3. The VirB7XAC2622 N-terminus recognizes the VirB9XAC2620 C-terminal domain. (A) Superposition of the
15N-HSQC spectra of
15N-
VirB7XAC2622_24–139 alone (orange) and in the presence of
14N-VirB9XAC2620_154–255 (green). (B) Same as A, but with a close-up view of the central
spectral region. The residues for which significant changes in peak positions were observed upon complex formation are indicated. (C) Weighted
chemical shift changes (Ddcomp) of VirB7XAC2622 upon binding to VirB9XAC2620. (D) Residues affected by interaction with VirB9XAC2620_154–255 (residues
27–41; red) are color coded on the structure of VirB7XAC2622_24–139.
doi:10.1371/journal.ppat.1002031.g003
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symptoms in orange leaves under the experimental conditions
tested. Similarly, a T4SS knockout failed to affect the pathogenicity
of X. campestris pv. campestris on several host plants [43]. Xac
pathogenicityincitrusandcankersymptomsarestronglydependent
on the action of virulence factors secreted by the Type III secretion
system [13]. The T4SS is probably involved in other, as yet
unidentified, cellular functions. As noted in the Introduction, the
Xac pXAC64 megaplasmid codes for a second T4SS probably
involved in plasmid mobilization [15,27] and whose structural
components exhibit only very low sequence identity to their
counterparts in the chromosomally encoded T4SS under study.
For example, its VirB9 and VirB10 homologs (XACb0039 and
XACb0038) are only 23–24% identical to VirB9XAC2620 and
VirB10XAC2619 [15]. Furthermore, the pXAC64 plasmid does not
code for any proteins with similarity to VirB7XAC2622 or any other
known VirB7 proteins [15]. Therefore, it is unlikely that the two
Xac T4SSs exercise redundant functions.
Discussion
The structure of the outer membrane complex of the T4SS
coded by the conjugative E. coli plasmid pKM101 has been
determined by X-ray crystallography and consists of 14 repeats of
Figure 4. TheconformationoftheVirB9XAC2620C-terminaldomain
changes significantly upon interacting with VirB7XAC2622.
15N-HSQC spectra of
15N-VirB9XAC2620_154–255 in the absence (red) and
in the presence (green) of
14N-VirB7XAC2622_24–139. Spectra were
collected at 30uC on a 500 MHz spectrometer equipped with a room
temperature probe.
doi:10.1371/journal.ppat.1002031.g004
Figure 5.
15N relaxation data for VirB7XAC2622_ _24–139. (A) Heteronuclear {
1H}-
15N NOE (HetNOE), (B)
15N-T1 and (C)
15N-T2 relaxation rates as a
function of the protein sequence. Black squares:
15N-VirB7XAC2622_24–139 at 800 mM; red circles:
15N-VirB7XAC2622_24–139 at 100 mM; blue inverted
triangles:
15N-VirB7XAC2622_24–139 –
14N-VirB9XAC2620_154–255 complex at 400 mM. Data are presented as mean 6 uncertainty of the fitted parameter.
Relaxation parameters for residues involved in oligomerization (43–47 and some between positions 86 and 93) were not obtained because they were
not detectable in the
15N HSQC spectrum at high protein concentration (800 mM) and display amplitudes too low to allow precise measurements at
lower concentrations.
doi:10.1371/journal.ppat.1002031.g005
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PLoS Pathogens | www.plospathogens.org 8 May 2011 | Volume 7 | Issue 5 | e1002031Figure 6. A complex between VirB7XAC2622, VirB9XAC2620 and VirB10XAC2619 is formed in vivo in Xac cells. (A) Immunoblot analysis of
VirB9XAC2620, VirB7XAC2622 and VirB10XAC2619 protein levels in bacterial total protein extracts. Polyclonal antibodies raised against VirB9XAC2620 (a-
VirB9XAC2620), VirB7XAC2622 (a-VirB7XAC2622) and VirB10XAC2619 (a-VirB10XAC2619) were used. Rec: purified recombinant proteins used as positive
controls; WT: Wild type Xac strain; DvirB7: DvirB7XAC2622 knockout strain and DvirB7+pVirB7: DvirB7XAC2622 knockout cells complemented with the
pUFR-VirB7 plasmid. Recombinant VirB7XAC2622_24–139 has a slightly greater electrophoretic mobility than native VirB7XAC2622, possibly due to the
presence of a covalently attached lipid moiety or retention of the signal sequence of the native protein. VirB9XAC2620_34–255 (26 kDa) and
VirB10XAC2619_85–389_His (34 kDa) are also smaller than the respective native proteins. (B) Coimmunoprecipitation assays detecting reciprocal
interactions between VirB proteins. Xac total cell lysates were immunoprecipitated (IP) with anti-VirB7XAC2622, anti-VirB9XAC2620 or anti-VirB10XAC2619
serum and the presence of VirB7, VirB9 or VirB10 was detected by immunoblot analysis. Lane labels are the same as in part (A). No VirB proteins were
detected in control experiments using pre-immune sera (data not shown). (C) Characterization of the DvirB7XAC2622 gene knockout in Citrus sinensis
infections. Macroscopic symptoms on abaxial surface of orange leaves 12 days post inoculation with wild type (left) and DvirB7 (right) strains of Xac.
(D) Growth curves of Xac strains on orange leaves. Blue: wild type; red: DvirB7. Data are presented as mean 6 standard deviation.
doi:10.1371/journal.ppat.1002031.g006
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the C-terminal domain of VirB9 and the C-terminal domain of
VirB10, respectively. This structure revealed that the inner lining
of the channel is formed by the C-terminal domains of the 14 TraF
subunits. The TraN-TraO subcomplexes surround the internal
ring formed by TraF. The 33 residue long lipidated TraN subunit
is the outermost subunit of the complex whose external diameter is
172 A ˚ [34].
Xanthomonas VirB7 Structure and Interactions in the
Context of the T4SS Core Complex
VirB7XAC2622 is structurally distinct from all VirB7 homologs
characterized to date. Its structural motifs are illustrated in
Figure 7A. Like all other VirB7 proteins, it has a signal peptide, a
conserved cysteine residue (Cys22) within a lipobox for covalent
attachment to outer membrane lipids and a short extended region
involved in interaction with VirB9. These motifs are all contained
within the first 41 residues, which corresponds relatively well with
the size of the majority of unprocessed VirB7 proteins (45–65
amino acids) [36].
VirB7 proteins are very poorly conserved though it has been
observed that many proteins of this family have in common a
PVNK motif that is involved in the interaction with VirB9 [35].
The VirB9 binding site in VirB7XAC2622 includes a HVNH
sequence (residues 36–39) found in almost all Xanthomonadaceae
orthologs (PVNR in X. albilineans and Stenotrophomonas maltophilia)
which aligns with a perfect PVNK motif in the Neisseria sp. oral
taxon 014 str. F0314 ortholog (Figure 7B). The side chains of the
two most conserved residues of this motif, Val and Asn, make
intimate contacts with TraO/VirB9 in the pKM101 outer
membrane complex structure [35]: the Val side chain is inserted
between the two TraO b-sheets while the Asn amide Od1 and
Nd2 atoms makes a set of three H-bonds with the TraO main
chain. Furthermore, the PVNK motif in TraN is preceded by an
approximately 10 amino acid segment that makes contacts with
TraO, including a 3 residue b-strand that adds to the edge of one
of the TraO b-sheets [34]. The corresponding regions in
VirB7XAC2622 are precisely those that demonstrate the greatest
chemical shift perturbations upon binding to VirB9XAC2620
(Figure 3). This suggests that interactions between VirB7XAC2622
and VirB9XAC2620 are very similar to that observed in the TraN-
TraO complex.
The VirB7-VirB9 interactions described are most likely respon-
sible for the loss of conformational flexibility observed for the N-
terminal tail of VirB7XAC2622 and the C-terminal domain of
VirB9XAC2620. Furthermore, interaction with VirB7XAC2622 is likely
to be accompanied by a significant change in the structure of
VirB9XAC2620_154–255, as revealed by the very large chemical shift
perturbations observed for the majority of the
1H-
15N cross-peaks
(Figure 4). These changes in VirB9XAC2620 structure and dynamics
may be related to its instability in vivo in the absence of
VirB7XAC2622. Our immunoblot and coimmunoprecipitation data
suggest that VirB7XAC2622, VirB9XAC2620 and VirB10XAC2619 form
a stable trimeric complex in vivo and that the stabilities of
VirB9XAC2620 and VirB10XAC2619 are dependent on VirB7XAC2622
(Figure 6). This may be a physiologically relevant mechanism by
which excess VirB9 and VirB10 are degraded to maintain proper
VirB7-VirB9-VirB10 stoichiometry.
VirB7XAC2622 hasa mosaic structure (Figure 7A).Inaddition tothe
canonical VirB7-like N-terminal region, VirB7XAC2622 has a C-
terminal region that includes a globular domain (residues 52–133).
This globular domain does not interact with VirB9XAC2620_154–255
but does interact with an extended region (residues 42–49) that
immediately precedes the globular domain in another VirB7XAC2622
molecule (Figure 2D), leading to the formation of homo-oligomers.
The unique structural features of VirB7XAC2622 raise the question of
how they may be incorporated into the model for the T4SS outer
membrane complex tetradecamer previously solved for the pKM101
conjugation machine [34]. Specifically: can VirB7XAC2622 oligomer-
ization occur while maintaining VirB7-VirB9 interactions in the
context of the pore? And how are the VirB7XAC2622 globular
domains oriented with respect to the pore? In order to investigate
these questions, we used the VirB7XAC2622-TraN alignment depicted
in Figure 7B to manually place 14 different NMR models of residues
37–139 of VirB7XAC2622 (VirB7XAC2622_37–139) around a tetradeca-
meric ring made up of TraOCT subunits derived from the pKM101
TraN-TraOCT-TraFCT structure [34]. The VirB7XAC2622_37–139
subunits were placed so that Val37 and Asn38 occupied positions
similar to Val33 and Asn34 of TraN. This (VirB7XAC2622_37–139-
TraOCT)14 complex was used as a starting model in a molecular
dynamics simulation in which the following restraints were used: i)
The 14 TraOCT subunits were fixed in space, ii) VirB7XAC2622
residues 37 and 38 were fixed in space and iii) intermolecular NOE
derived distance restraints were placed on 5 hydrogen pairs between
neighboring VirB7XAC2622 subunits. During the initial cycles of the
moleculardynamicssimulation,thedistanceobservedbetweenthe13
intermolecular VirB7XAC2622 hydrogen pairs for which NOEs were
measured (Figure2D and Results above) decreases from the 12–25 A ˚
range observed in the starting model to a 4–7 A ˚ range, consistent
with observation of NOE signals. These short contact distances are
then observed throughout the simulation for all 14 VirB7XAC2622 pair
interfaces made up of residues A43, T45, E46, I47, L49 in one
VirB7XAC2622 molecule and residues T63, S85, D86, Y87, T88, I90
in a neighboring VirB7XAC2622. This is a consequence of the strong
distance restraints included in the potential energy function. The
final molecular dynamics configuration is shown in Figure 7C.
Adding models of TraN residues 19–32 to represent VirB7XAC2622
residues 22–36 (see alignment in Figure 7B) and TraFCT (to
represent VirB10XAC2619) results in the structure shown in
Figure 7D made up of 14 repeats of VirB7XAC2622_37–139,
TraN19–32, TraOCT and TraFCT. This can be seen as putative
model for the VirB7XAC2622-VirB9XAC2620-VirB10XAC2619 outer
membrane complex. Note that in Figures 7C and 7D, the VirB7 N0
domains (dark blue) adopt a variety of orientations with respect to
the central ring and the membrane normal. This flexibility is
derived from the conformational freedom of the VirB7XAC2622
regions immediately before and after residues 42–49 (magenta)
involved in VirB7-VirB7 interactions.
Our proposal of a physiological role for VirB7XAC2622
oligomerization is supported by an analysis of conserved residues
in the small group of full-length VirB7XAC2622 homologs found in
Xanthomonadaceae and the two Neisseria species Neisseria flavescens
SK114 and Neisseria sp. oral taxon 014 str. F0314. An alignment of
VirB7XAC2622 and the two Neisseria proteins is shown in Figure 7B.
The three proteins have only 21% sequence identity. However, 6
out of 11 of the residues involved in intermolecular NOEs at the
B7-B7 interface (E46, I47, L49, T63, D86 and T88) are absolutely
conserved in all Xanthomonadaceae, Neisseria str. F0314 and
Neisseria flavescens and is either Phe or Tyr at position 87. Thus, the
oligomerization interface is well conserved in an otherwise highly
diverse protein family.
VirB7XAC2622 oligomerization is different from the dimerization
observed in the canonical VirB7 protein from A. tumefaciens [30]
which occurs via the formation of disulfide bonds involving residue
24. The structure of the outer membrane complex [34] however, is
not compatible with the maintenance of these disulfide bonds in a
fully assembled T4SS. Furthermore, VirB7XAC2622 does not have
any cysteine residues other than at the N-terminal lipidation site.
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PLoS Pathogens | www.plospathogens.org 10 May 2011 | Volume 7 | Issue 5 | e1002031Figure 7. VirB7XAC2622 structure and interactions in the context of the T4SS outer membrane complex. (A) Schematic organization of
the VirB7XAC2622 protein, based on bioinformatics and experimental data. (B) Sequence alignment of the VirB7 proteins from Xanthomonas citri subsp.
citri (GenBank code AAM37471), Neisseria flavescens (EER57212), Neisseria sp. oral taxon 014 str. F0314 (EFI23373) and TraN from pKM101 (AAA86456).
Sequences begin at the cysteine residues of the predicted lipidation sites. Black asterisks indicate residues involved in observed intermolecular NOEs.
Blue asterisks indicate the PVNK motif found in the pKM101 TraN protein. Blue brackets above and below the alignment indicate the VirB9XAC2620 and
TraO binding sites in VirB7XAC2622 and TraN, respectively. The black bracket indicates the N-terminal oligomerization site. Residues outlined in red are
conserved in at least three of the four sequences. Note that the codon for V55 of the protein from Neisseria flavescens is incorrectly assigned as a start
codon in the GenBank database. (C) Final molecular dynamics configuration of the (VirB7XAC2622_37–139-TraOCT)14 complex. TraOCT is represented in
red, VirB7XAC2622 is in cyan (residues 37–41), magenta (residues 42–49) and dark blue (residues 50–139). One VirB7XAC2622_37–139 unit is shown in
green. (D) Putative model for the VirB7XAC2622-VirB9XAC2620-VirB10XAC2619 outer membrane complex produced by adding TraN residues 19–32
(representing VirB7XAC2622 residues 22–36, see alignment in part B) and TraFCT (representing VirB10XAC2619) to the structure shown in part C. The color
scheme is the same as in part C except that cyan represents VirB7XAC2622 residues 22–41 and TraF/VirB10 is shown in yellow. One complete
VirB7XAC2622 molecule is shown in green.
doi:10.1371/journal.ppat.1002031.g007
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to Proteins Associated with Transport Across Bacterial
Outer Membranes
The VirB7XAC2622 globular domain has no significant sequence
similarity to proteins of known structure. We therefore used the
Dali Server [44] to search for proteins with similar topology to this
domain. This analysis revealed that the VirB7XAC2622 folded
region resembles domains found in the following proteins (Table 3
and Figure 8): i) the TonB-dependent receptors (periplasmic
signaling domain; Figure 8A) [45,46], ii) the outer membrane
secretin channel GspD from the type II secretion system (T2SS;
Figure 8B) [47], iii) the secretin EscC from the Type III secretion
system (T3SS; Figure 8C) [48], iv) the needle-like cell-puncturing
device components gp27 and gp44 from long-tailed phages like T4
and Mu (Figure 8D) [49,50] and v) the Type VI secretion system
(T6SS) protein VgrG (superposition not shown) [51]. These
domains are found at the N-termini of T2SS and T3SS secretins
and have been denominated N0 domains which have also been
identified in the Type IV pilus secretin PilQ [47] and the
filamentous phage secretin pIV [52]. It is striking that in spite of its
small and compact nature, domains with the VirB7XAC2622
topology are found only in a restricted number of proteins, all of
which are involved in the transport of molecules across bacterial
outer membranes. These observations suggest that all of these
proteins may be distantly related and have evolved in the
periplasm or outer membrane to adopt a variety of functions,
from structural modules in outer membrane pores (secretins from
type II and type III secretion systems, type IV pili and filamentous
phages) to membrane-penetrating devices in T6SS and long-tailed
bacteriophages, and signal-transduction modules in TonB-
dependent receptors.
Nakano et al. [53] have recently described the crystal structure
of the DotD lipoprotein of the Type IV-B secretion system from
Legionella pneumophila. Type IV-B secretion systems have weak or no
sequence similarity with the larger group of Type IV-A secretion
systems [54] to which the Xanthomonad T4SS pertains.
Interestingly, the DotD crystal structure presents a C-terminal
region with an N0 domain topology similar to that of
VirB7XAC2622 structure (Figure 8E), though the proteins present
no significant sequence similarity. An interesting difference
between the two structures is that a 6 amino acid sequence (called
the ‘‘lid’’) of the otherwise disordered N-terminal region is visible
in the crystal structure and makes b-strand addition to b1. This
interaction is different from that observed in the VirB7XAC2622
oligomer described here. Since no electron density for the 23
residues between the lid and the N0 domain were visible, it was
not clear whether they come from the same molecule in the crystal
lattice. We therefore predict that DotD will eventually be shown to
exhibit the same characteristics as VirB7XAC2622, namely to
interact with both a VirB9-like protein and to form head-to-tail
polymeric rings based on interactions between the flexible N-
terminal region and globular N0 domains of neighboring subunits.
This analysis points to previously unrecognized common structural
features between the outer membrane complexes of Type IV-A
and Type IV-B secretion systems.
The novel VirB7XAC2622 structure, its oligomerization and its
interaction with VirB9 described here point to a possible structural
variation in the Xanthomonas T4SS that could result in the
formation of an extra ring layer in the core complex. While the
VirB7-VirB7 interactions observed in the NMR experiments were
of relatively low affinity (fast exchange chemical shift changes were
observed in the 7–850 mM range), these interactions would be
strengthened by the increased effective concentration afforded by
the fourteen neighboring VirB7XAC2622 binding sites on the outer
surface of the VirB9/VirB10 ring. Several hypotheses regarding
the physiological role of this VirB7XAC2622 ring can be proposed.
One possibility is that the weak B7-B7 interactions break and
reform again to accommodate different conformational states of
the outer pore during substrate translocation or to permit allosteric
communication between the outer and inner membrane core
complexes. Another possibility is that the VirB7XAC2622 N0
domains could act as a conduit for signal transmission between
substrates or signaling molecules in the periplasm and the VirB9
and VirB10 subunits. Whether the VirB7XAC2622 N0 domain
carries out a purely structural function or is involved in substrate
recognition or signal transduction will have to be tested in the
future.
Materials and Methods
Cloning, Protein Expression and Purification
Plasmids, oligonucleotides and bacterial strains used in this
study are listed in Table S1. The DNA fragments encoding
residues 24–139 of VirB7XAC2622 (GenBank AAM37471), 154–
255 of VirB9XAC2620 (GenBank AAM37469) and 85–389 of
VirB10XAC2619 (GenBank AAM37468) were amplified by PCR
from Xanthomonas citri subsp. citri strain 306 genomic DNA and
inserted into the pET28a expression vector (Novagen) using the
NdeIa n dXhoI( V i r B 7 XAC2622)o rNdeIa n dBamHI (VirB9XAC2620
and VirB10XAC2619) cloning sites, to express the recombinant
proteins fused with an N-terminal His-tag. DNA fragments
encoding residues 51–134 of VirB7XAC2622 and 34–255 of
VirB9XAC2620 were cloned into the pET11a vector (Novagen)
using NdeIa n dBamHI sites. All constructs were confirmed by
DNA sequencing. E. coli BL21(DE3)RP and BL21(DE3)Star
strains (Novagen) were transformed with the recombinant
plasmids for expression of the protein products which are re-
ferred to as VirB7XAC2622_24–139_His,V i r B 9 XAC2620_154–255_His,
VirB7XAC2622_51–134,V i r B 9 XAC2620_34–255 and VirB10XAC
2619_85–389_His. Cells were grown in 2XTY for expression of
unlabeled proteins or in M9 minimal media containing
15NH4Cl and
12C-glucose or
13C-glucose (Cambridge Isotope
Laboratories) for production of
15No r
15Na n d
13C isotopically
labeled proteins. Recombinant protein expression was induced
at midlog phase by the addition of 0.5 mM isopropyl
b-D-1-thiogalactopyranoside and the cells were grown for four
Table 3. Structural similarity of the VirB7XAC2622 globular
domain
a.
PDB Description
XR
b - Z-score/
RMSD (A ˚)
NMR
c - Z-score/
RMSD (A ˚)
2A02 PupA – TBDRSD 7.0/2.5 7.3/3.0
1ZZV FecA – TBDRSD 6.5/2.9 6.8/2.6
3GR5 EscC – T3SS 6.2/2.9 6.1/3.0
3ADY DotD – T4SS-B 6.1/3.1 5.7/2.9
1WRU gp44 – Mu phage 6.1/3.3 5.7/3.9
2IAH FpvA – TBDRSD 6.0/2.5 6.0/2.7
3EZJ GspD – T2SS 5.2/2.7 5.0/2.8
aStructural comparisons were done using the DALI-server [44].
bXR: Analysis performed with the X-ray crystal structure of VirB7XAC2622_51–134.
cNMR: Analysis performed with the lowest energy NMR model of
VirB7XAC2622_24–139 (residues 51–134). TBDRSD: TonB-dependent receptor
signaling domain.
doi:10.1371/journal.ppat.1002031.t003
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In the case of VirB7XAC2622_24–139_His and VirB9XAC2620_154–255_His,
thelysissupernatantswereseparatedbypassagethroughQ-Sepharose
(VirB7XAC2622_24–139_His)orSP-Sepharose(VirB9XAC2620_154–255_His)
ion exchange columns (GE Healthcare) followed by affinity chroma-
tographyusinganickelaffinitycolumn.TheN-terminalHis-tagswere
removed using the Thrombin CleanCleave kit (Sigma), creating the
proteins VirB7XAC2622_24–139 and VirB9XAC2620_154–255.Af i n a l
purification step consisted of passage through a Superdex 75 26/60
size exclusion column (GE Healthcare). VirB7XAC2622_51–134 was
purified using Q-sepharose anion exchange and Superdex 75 gel
filtration chromatography. VirB9XAC2620_34–255 and VirB10XAC
2619_85–389_His are expressed as insoluble proteins present in inclusion
bodies.Afterlysis,VirB9XAC2620_34–255wassolubilizedinthepresence
of 8 M urea and purified by SP-Sepharose cation exchange and
Superdex75sizeexclusionchromatographiesusingbufferscontaining
8Mu r e a .V i r B 1 0 XAC2619_85–389_His was purified by affinity chroma-
tography using buffers containing 8 M urea. Purified proteins were
refolded by successive dialysis against decreasing concentrations of
urea in 10 mM sodium acetate (pH 5.0) for VirB9XAC2620_34–255 or
10 mM Tris-HCl (pH 8.0), 150 mM NaCl for VirB10XAC2619_85–
389_His. Synthetic peptides corresponding to VirB7XAC2622_24–46 and
VirB7XAC2622_38–52 were purchased from Biomatik Corporation
(Cambridge, Ontario, Canada) and EZBiolab (Carmel, Indiana,
USA), respectively.
NMR Spectroscopy
NMR samples containing
15No r
15N/
13C labeled protein were
prepared in 10 mM
2H-sodium acetate (pH 5.0), containing
50 mM sodium chloride, 0.05% (w/v) sodium azide, 7% (v/v)
2H2O and 1 mM trimethylsilyl-2,2,3,3-tetradeuteropropionic acid
as internal standard for
1H chemical shift referencing. NMR
spectra were acquired on a 600 MHz Varian Unity-Inova
spectrometer equipped with inverse triple resonance (
1H,
15N,
13C) cold probe, or on BRUKER 500 MHz DRX or 800 MHz
Avance III spectrometers equipped with inverse triple resonance
(
1H,
15N,
13C) room temperature probes. Unless otherwise
mentioned, all NMR experiments were performed at 40uC. The
backbone resonance assignment of
15N/
13C-VirB7XAC2622_24–139
was achieved by analyzing the following three-dimensional
spectra: HNCA, HN(CO)CA, HNCO, HN(CA)CO, HNCACB
and CBCA(CO)NH [55]. Side-chain resonance assignments were
determined by analyzing the following spectra: 2D
13C-HSQC,
2D TOCSY, 2D NOESY, 3D HNHA, 3D HBHA(CBCA-
CO)NH, 3D
15N-TOCSY-HSQC, 3D H(CCO)NH-TOCSY,
3D (H)CC(CO)NH-TOCSY, 3D
15N-NOESY-HSQC, 3D
H(C)CH-TOCSY and 3D
13C-NOESY-HSQC (specific for the
aliphatic or the aromatic regions). The 3D H(C)CH-TOCSY and
3D
13C-NOESY-HSQC spectra were recorded in .99% (v/v)
2H2O. NOESY experiments were carried out using 0.2–0.3 mM
protein samples and all NOESY mixing times were 100 ms.
Backbone resonance assignments for
15N/
13C-VirB7XAC2622_
24–139 in complex with unlabeled VirB9XAC2620_154–255 were
obtained from the analysis of three-dimensional HNCA,
HN(CO)CA, HNCO, HNCACB, CBCA(CO)NH, HBHA(CB-
CACO)NH and
15N-NOESY-HSQC experiments recorded on a
sample of
15N/
13C-VirB7XAC2622_24–139 in the presence of a 20%
molar excess of unlabeled VirB9XAC2620_154–255. The backbone
resonance assignment (
15N and
1H) for VirB7XAC2622_51–134 was
performed by comparison with the
15N-HSQC spectrum of the
larger construct, VirB7XAC2622_24–139. Residual
1DNH dipolar
couplings for VirB7XAC2622_24–139 (0.25 mM), alone or in complex
with VirB9XAC2620_154–255, were determined from the differences
in
1H-
15N splittings obtained in isotropic and anisotropic media.
The
1H-
15N splittings were extracted from a series of J-modulated
2D
1H-
15N-HSQC experiments acquired at 30uC on the
500 MHz spectrometer, and analyzed essentially as described
[56]. Residual alignment was induced by a liquid crystalline
medium consisting of 5% penta-ethyleneglycol monododecyl ether
(C12E5)/n-hexanol (r=0.96) [57]. Fittings of RDCs to the NMR
and X-ray structures were carried out using PALES [58] or
MODULE [59]. All NMR spectra were processed with NMRPipe
[60] and analyzed with CCPN Analysis [61]. Resonance
assignments were deposited in the Biological Magnetic Resonance
Data Bank (BMRB accession code 17257).
NMR Structure Calculation
Structure calculation and automated NOE assignment were
performed using CYANA 2.1 [37]. Chemical shifts of
1Ha,
13Ca,
13Cb,
13C9 and
15N
H were used as input for TALOS [62] to
predict Q and y dihedral angles that were subsequently used as
restraints in the structure calculation. A total of 3471 NOE cross
peaks were manually picked in the
15N-NOESY-HSQC and
13C-
NOESY-HSQC (acquired specifically for the aliphatic or the
aromatic regions) spectra and used as input for CYANA. The
CYANA protocol consisted of 7 cycles of simulated annealing in
torsion angle space with 10000 integration steps. In each cycle 300
conformers were calculated. The intra-residue, sequential and 10
Figure 8. Superposition of the structure of the VirB7XAC2622 N0 domain with structural homologs. The VirB7XAC2622 globular domain
(residues 51–134; green) is superposed with (A) the signaling domain of PupA (orange, residues 3–76, PDB: 2A02); (B) the N0 domain of GspD (red,
amino acids 3–79, PDB: 3EZJ); (C) the N0 domain of EscC (yellow, amino acids 31–103, PDB: 3GR5), (D) residues 97–176 of gene product 44 from
bacteriophage Mu (light blue, PDB: 1WRU) and (E) residues 81–161 of DotD from L. pneumophila (purple, PDB: 3ADY).
doi:10.1371/journal.ppat.1002031.g008
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and imposed during all stages of the protocol. Chemical shift
tolerances for automated NOE assignment were set to 60.025 ppm
in the direct
1H dimension, 60.030 ppm in the indirect
1H
dimension and 60.25 ppm for the heteronuclei. The best 50
CYANA solutions were selected based on a target function criteria,
and further refined in explicit water using CNS2.1 and HAD-
DOCK2.0 [41]. The 1616 NOEs assigned by CYANA, the
manually assigned NOEs, and the TALOS dihedral angle restraints
were used as input during water refinement in HADDOCK. The
best 20 lowest-energy conformers after water refinement were
deposited in the Protein Data Bank (PDB code 2L4W). The quality
of the final NMR structures was investigated by PROCHECK-
NMR [63] and PSVS [64]. The structures were visualized using
MOLMOL [65] or PYMOL (http://www.pymol.org).
15N Relaxation Measurements
Experiments for measuring backbone
15N longitudinal (T1)a n d
transverse (T2) relaxation times, and the heteronuclear {
1H}-
15N
NOE, were recorded at 40uC on a Varian Inova 600 MHz
spectrometer using standard Biopack pulse sequences (Varian, Inc.).
The inversion recovery delays used for sampling T1 relaxation were
50,250, 450,650,850, 1050,1250,1450 and1650 ms.TheCPMG
delays used for sampling T2 relaxation were 10, 30, 50, 70, 90, 110,
130, 150, 170, 190 and 210 ms. The
1H saturation period in the
heteronuclear {
1H}-
15N NOE experiment was 3 s. All 2D spectra
were acquired sequentially as matrices of 512(
1H)6128(
15N)
complex points, and inter scan delay of 3 s. Relaxation rates were
obtained by fitting the time decay of peak intensities to an
exponential decay function with three fitted parameters, the
relaxation rate, the intensity at time zero and an offset, using the
CCPN Analysis software [61]. Overall rotational correlation times
(tc) were obtained either from the mean ratios of
15NT 1/T2
relaxation rates of
1H-
15N bond vectors located in regions of
secondary structure using TENSOR2 [66], or from estimates of
15N
T1 and T2 relaxation times obtained from 1D
15N-edited relaxation
experiments, as previously described [67,68].
NMR Titration Experiments
Unlabeled VirB9XAC2620_154–255 or VirB9XAC2620_34–255 were
titrated into a solution of
15N-labeled VirB7XAC2622_24–139 and a
15N-HSQC spectrum was acquired after the addition of each
aliquot until a molar excess of 1.5 of unlabeled protein with respect
to
15N-VirB7XAC2622_24–139. In analogous experiments
15N-
labeled VirB9XAC2620_154–255 was titrated with unlabeled VirB7-
XAC2622_24–139 or VirB7XAC2622_24–46. VirB7XAC2622_24–139 oligo-
merization was studied by monitoring changes in the
15N-HSQC
spectra as a function of protein concentration in the range of 7 to
850 mM.
15N-labeled VirB7XAC2622_51–134 was also titrated with
unlabeled VirB7XAC2622_38–52. Chemical shift perturbations due to
sample dilution or protein-protein interaction were obtained from
the weighted chemical shift changes in the
15N-HSQC spectra
calculated according to Eq. 1 [69]:
Ddcomp~½(DdHN)
2z(0:15|DdNH)
2 
1=2 ð1Þ
where DdH
N and DdN
H are the chemical shift changes (in ppm) of
the amide proton and nitrogen resonances, respectively.
Protein-Protein Docking
Docking simulations were used to build a docking model for the
dimer of VirB7XAC2622_24–139. The calculations were performed
with HADDOCK2.0 using CNS2.1 [41], and the first model of
the NMR ensemble as starting structure. The docking was driven
by unambiguous intermolecular NOEs and by ambiguous
interaction restraints (AIR) between active residues and active
plus passive residues. The following 13 NOE restraints were used:
Ala43Hb - Ile90Hd1; Thr45Ha - T88Hc2; Thr45Hb - T88Hc2;
Glu46Hb - Tyr87He; Ile47Hd1-T h r 6 3 H b; Ile47Hd1-T h r 6 3 H c2;
Ile47Hd1 - T88Ha;I l e 4 7 H d1 - T88Hc2; Leu49Hc - Ser85Ha;
Leu49 Hd1-A s p 8 6 H a; Leu49Hd1-A s p 8 6 H b1; Leu49Hd1-
Asp86Hb2a n dL e u 4 9 H d2 - Asp86Ha. Active residues were
identified as those showing chemical shift perturbations of at least
one standard deviation above the mean, for
15N-VirB7XAC2622_24–139
as a function of protein concentration (Figure 2). Active residues were
E42, A43, T45, E46 and I47 at the N-terminal tail of the first subunit
and D86, T88, I90, G91, Q115 of the C-terminal globular domain of
the second subunit. Passive residues were F40, D41, P44, P48 and
L49 in the N-terminal segment, and P84, S85, Y87, P92, A113 and
A114 in the C-terminal domain. The N-terminal tails (residues 24–
50) were kept fully flexible during all stages of the docking, while C-
terminal domain residues at the interface, 84–92, 61–63 and 113–
115, were maintained semi-flexible, being allowed to move only
during semi-flexible refinement. The rigid body stage consisted of the
calculation of 1000 solutions, from which 100 with the lowest
HADDOCK scores were selected for semi-rigid simulated annealing
in torsion angle space including backbone and side chain flexibility,
and final refinement in Cartesian space with explicit water. The
refined solutions were then clustered based on the backbone RMSD
at the interface. An analogous protocol was used for docking the N-
terminal (residues24–50)and C-terminal (residues51–139) fragments
of VirB7, except that in this calculation NOE restraints were not
included and flexibility was introduced only at the interface.
Model Building and Molecular Dynamics Simulations
Models of residues 37–139 of VirB7XAC2622 (VirB7XAC2622_
37–139) were positioned around a tetradecameric ring made up of
TraOCT subunits derived from the pKM101 T4SS TraN-TraOCT-
TraFCT structure [34]. The VirB7XAC2622_37–139 subunits were
placed so that Val37 and Asn38 occupied positions similar to Val33
and Asn34 of TraN. Molecular mechanics optimization and
dynamics were then carried out from this initial model. The
OPLS/AA force-field [70] for the protein and an implicit solvent
representation of the generalized Born-formalism [71] were used.In
addition to the molecular force-field, distance restraints with a flat-
bottom harmonic functional form were included such that an
energy penalty was added to the potential when the distance
between specified pairs of atoms was less than a minimum threshold
value of 3 A ˚ or exceeded a maximum of 6 A ˚. A harmonic force
constant of 5000 kJ?mol
21?A ˚ 22 was used. The following 5 NOE
proton pairs were specified for each VirB7XAC2622 pair interface:
Ala43Hb - Ile90Hd1, Thr45Hb - T88Hc2, Ile47Hd1 - Thr63Hb;
Leu49Hc - Ser85Ha; and Leu49Hd2 - Asp86Ha. These pairs
correspond to a subset of the pairs for which intermolecular NOEs
were detected. Thus, a total of 70 (1465) distance restrains were
included in the potential. All ionizable residues besides histidine
were treated in their charged forms. Molecular dynamics were
carried out at a temperature of 300 K for a total time of 2 ns. All
computations were carried out with the GROMACS 4.5.3 software
[72].
Crystallization, Data Collection and Processing
A construct corresponding to the VirB7 C-terminal region,
VirB7XAC2622_51–134, at 14 mg/mL in 5 mM Tris-HCl pH 7.5
and 25 mM sodium chloride, was submitted to vapor diffusion
sitting-drop crystallization trials at 18uC. Large plates appeared
after one day over a reservoir solution comprising 1.4 M
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solution supplemented with 25% (v/v) glycerol was used as
cryoprotectant. Crystals were flash frozen at 100 K and submitted
to X-ray diffraction at beam line W01B-MX2 of the Brazilian
Synchrotron Light Laboratory (LNLS) coupled to a Marmosaic-
225 CCD detector (Mar, USA). The diffraction data were
indexed, integrated and scaled using HKL2000 [73].
X-ray Structure Determination and Refinement
The crystal structure of VirB7XAC2622_51–134 was determined by
molecular replacement by Phaser [74] using residues 51–134 of
the lowest energy NMR structure as the search model. The model
was iteratively refined using the graphics program Coot [75] with
rounds of restrained refinement in Refmac5 [76] with individual
anisotropic B-factor for all non-hydrogen atoms. All programs
used for refinement were from the CCP4 suite [77]. The quality of
the structure was analyzed by the programs Coot, Refmac5,
Procheck [78], Rampage [79] and MolProbity [80]. The
coordinates of the crystal structure were deposited in the PDB
(PDB code 3OV5).
Fluorescence Spectroscopy
Fluorescence experiments were conducted in an AVIV ATF-105
spectrofluorimeter (AVIV Instruments). Fluorescence emission
was collected after successive addition of 0.1 mM VirB7XAC2622_
24–139_His aliquots into a sample containing 1 mM VirB9XAC2620_
34–255 in 5 mM sodium acetate (pH 5.0). The final VirB7XAC
2622_24–139_His concentration in the titration was 2.2 mM. Samples
were pre-equilibrated for 2 min at 25uC, excited at 280 nm (2 nm
bandwidth) and fluorescence emission was detected from 334–
342 nm (7 nm bandwidth) at 2 nm intervals. The dissociation
constant was calculated from a nonlinear regression fit of
fluorescence titration data to Eq. 2 [81,82], using the SigmaPlot
program (SPSS, Inc.):
F~ v=V ðÞ ((a{1)=
2X) (    X ½  z Y ½  zKd{ X ½  z Y ½  zKd ðÞ
2

{4X ½  Y ½ 
 1=2 
z1)
ð2Þ
where F is the fluorescence intensity at any given point of the
titrationcurve,v is the initialvolume, V is volume at any given point
of the titration, [X] and [Y] are the VirB9XAC2620_34–255 and
VirB7XAC2622_24–139_His concentrations at any given point of the
titration, respectively, Kd is the dissociation constant and a is the
ratio between the maximum fluorescence intensity and the initial
fluorescence intensity.
Glutaraldehyde Cross-Linking Experiments
Samples with different concentrations of VirB7XAC2622_24–139 or
VirB7XAC2622_51–134 were pre-equilibrated for 15 min, and then
incubated with 0.01% (v/v) glutaraldehyde. After 20 min, the
cross-linking reaction was stopped by the addition of SDS-PAGE
sample buffer (100 mM Tris-HCl pH 6.8, 3.7% (w/v) SDS,
18.7% (v/v) glycerol, 140 mM 2-mercaptoethanol and 0.01% (w/
v) bromophenol blue). The cross-linking products were analyzed
by 16% Tricine SDS-PAGE [83].
virB7XAC2622 Knockout and Complementation
Approximately 1 kb of the upstream and downstream regions of
the virB7XAC2622 gene were amplified by PCR from Xac genomic
DNA and the two fragments were ligated to produce an in frame
deletion, leaving only the region coding for the first three and last
five codons. This sequence was then cloned into the BamHI
restriction site of the pNPTS138 suicide vector (M. R. Alley,
unpublished), thereby generating the plasmid pNPTS-Dxac2622.
This vector was introduced into Xac by electroporation and
replacement of the wild-type copy by the deleted version was
obtained after two recombination events as described [84]. In
order to complement the virB7XAC2622 knockout, a fragment
including the virB7XAC2622 gene plus 1000 pb of upstream
sequence was amplified by PCR from Xac genomic DNA and
inserted into the pUFR047 vector [85] at the BamHI restriction
site, creating the plasmid pUFR-VirB7. This plasmid was then
transferred to the DvirB7XAC2622 strain by electroporation and
selection of gentamicin resistance.
In planta Studies
Virulence assays were performed by infiltration of the Xac
strains into sweet orange leaves (Citrus sinensis L. Osbeck). The cell
cultures were adjusted to an optical density of 0.1 at 600 nm and
leaves were inoculated by syringe infiltration with needle. The
plants were maintained at 28uC with a 12 h photoperiod and the
development of the symptoms was regularly observed. Bacterial
growth was measured by harvesting 10 mm
2 citrus leaf discs for
each inoculated Xac strain, and the leaf discs were macerated in
150 mM sodium chloride. The solution was serially diluted and
spread onto LBON plates [1% (w/v) tryptone, 0.5% (w/v) yeast
extract and 1.5% (w/v) agar] containing ampicillin. The mean
number of colony forming units per square centimeter (CFU/cm
2)
was calculated by counting individual colonies obtained from each
dilution.
Antibody Production and Immunoblot
Rabbit polyclonal antibodies were raised against VirB7XAC2622_
24–139,V i r B 9 XAC2620_34–255 and VirB10XAC2619_85–389_His.T oa n a -
lyze protein levels in Xac, cellswere grown in XVM2 medium [86] to
an optical density (600 nm) of 1.0. Recombinant proteins and Xac
cellular extracts were separated by 18% SDS-PAGE followed by
immunoblot analysis. The rabbit sera were used at 1:1000 dilutions
and the antibodies were detected with staphylococcal protein A
conjugated to horseradish peroxidase (Sigma). Immunoblots were
developed with the ECL Advance Western Blotting system and
exposed to Amersham Hyperfilm ECL film (GE Healthcare).
Immunoprecipitation
Strains of Xac were grown in XVM2 to an optical density
(600 nm) of 1.0 and equal numbers of cells were harvested by
centrifugation. Cells were resuspended in 500 ml of 50 mM Hepes
(pH 8.0) containing 5 mM EDTA. Coimmunoprecipitation ex-
periments were performed after solubilization of cells with
deoxycholate (DOC) and N,N–Dimethyldodecylamine N-oxide
(LDAO) detergents, as described [87]. Bacterial suspensions were
treated with 200 mg/ml lysozyme for 1 h at 4uC. Cells were lysed
by sonication in the presence of 100 mM NaCl, 1% (w/v) DOC
and protease inhibitor cocktail (Sigma Aldrich). Volumes were
adjusted to 1 mL with 50 mM Hepes (pH 8.0) and 2% (w/v)
LDAO and lysates were solubilized by incubation for 16 h at 4uC
with agitation. Solubilized material was isolated by centrifugation
at 15,0006g for 20 min and incubated with Protein G agarose
beads (Millipore) for 4 h at 4uC, removing nonspecifically bound
proteins. For immunoprecipitation, supernatants from this pre-
clearing step were incubated with protein G agarose beads in the
presence of pre-immune serum (controls) or anti-VirB7, anti-
VirB9 or anti-VirB10 antibody, for 16 h at 4uC, with agitation.
The unbound material was discarded after centrifugation (4006g,
5 min) and beads were washed three times with decreasing
concentrations of LDAO and DOC (final wash contained 0.1%
ð2Þ
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agitation. Immunoprecipitates were eluted by addition of SDS
sample buffer and boiling for 10 min. Samples were analyzed by
SDS-PAGE followed by immunoblot.
Quantitative RT-PCR
RNAs from Xac cultures grown in XVM2 medium to an
optical density (600 nm) of 1.0 were extracted using Illustra
RNAspin Mini kit, according to manufacturer’s instructions (GE
Healthcare). Purified RNA was treated with 1 U/mg DNaseI,
RNase-free (Fermentas) and successful removal of contaminating
DNA was confirmed by PCR. Reverse transcription was
performed using 1 mg of DNaseI-treated RNA and RevertAid
H Minus First Strand cDNA Synthesis Kit, following manufac-
turer’s protocol (Fermentas). Quantitative amplification of the
resulting cDNA (40 ng) was performed using 0.3 mM of each
primer (F_virB9_RT and R_virB9_RT; Table S1) and SYBR
Green/ROX qPCR Master Mix in the ABI7300 Real-Time
System (Applied Biosystems). Relative quantification of gene
expression was performed using gene xac1631 (that codes for
subunit A of DNA gyrase) as an endogenous control and the
2
2DDCT method [88]. Primers were designed using the Primer-
Express Software (Applied Biosystems). Triplicates of two
independent biological samples were used.
Accession Numbers
1H,
13C and
15N resonance assignments of VirB7XAC2622 were
deposited in the BMRB: entry 17257. NMR and X-ray
crystallography coordinates have been deposited in the PDB with
accession codes 2L4W and 3OV5, respectively.
Supporting Information
Figure S1
15N-HSQC spectrum of
15N-VirB7XAC2622_24–139 at
7 mM, annotated with residue assignments. Side-chain
1H-
15N
resonances of asparagines, glutamines and tryptophans are also
indicated. The histidine 39 peak (H39) is below the contour level
in this picture and its position is indicated with a rectangle.
(TIF)
FigureS2 (A) VirB7XAC2622_51–134 crystals.(B)2Fo -Fc (1.5s:b l u e )
and Fo - Fc (3.0 s: green and 23.0 s: red) electron density maps.
(TIF)
Figure S3 The head-to-tail interaction of VirB7XAC2622.( A )
15N-
HSQC spectra of
15N-labeled VirB7XAC2622_51–134 (200 mM) titrated
with unlabeled VirB7XAC2622_38–52 (from 0 mM (cyan) to 740 mM
(black)). Note that some signals suffer line-broadening during the
titration and fall below the contour level in this picture. (B) Weighted
chemical shift changes (Ddcomp) of VirB7XAC2622_51–134 observed
upon addition of VirB7XAC2622_38–52. (C) Normalized weighted
chemical shift changes (Ddcomp(norm)), comparing the Ddcomp due
to VirB7XAC2622_24–139 oligomerization (yellow; data shown in
Figure 2B) and the VirB7XAC2622_51–134 -V i r B 7 XAC2622_38–52
interaction (blue; Figure S3B). The Ddcomp(norm) values were
calculated by dividing the Ddcomp values for each residue by the
Ddcomp value for residue I90 in each of the two experiments.
(TIF)
Figure S4 Glutaraldehyde cross-linking experiments of VirB7XAC
2622_24–139 (A) and VirB7XAC2622_51–134 (B). (A) VirB7XAC2622_24–139
at 720 mM (lanes 1–3), 240 mM( l a n e4 ) ,8 0mM( l a n e5 )a n d2 7mM
( l a n e6 )w e r ei n c u b a t e dw i t h o u t( l a n e1 )o rw i t h( l a n e s2 – 6 )0 . 0 1 %( v /
v) glutaraldehyde. The incubation in lane 2 also contained 1% (w/v)
SDS. (B) VirB7XAC2622_24–139 at 720 mM without (lane 1) or with
0.01% (v/v) glutaraldehyde (lane 2); VirB7XAC2622_51–134 at 720 mM
(lanes 3 and 4), 240 mM( l a n e5 )a n d8 0mM (lane 6) were incubated
without (lane 3) or with 0.01% (v/v) glutaraldehyde (lanes 4–6).
Although the reactions were performed with different protein
concentrations, the same amount of VirB7XAC2622_24–139 or
VirB7XAC2622_51–134 was loaded in each lane of the 16% Tricine
SDS-PAGE gel. MW: molecular weight marker.
(TIF)
Figure S5 VirB7XAC2622_24–139_His-VirB9XAC2620_34–255 interac-
tion studied by fluorescence. X-axis: concentration of VirB7XAC
2622_24–139_His. Y-axis: arbitrary fluorescence increase due to the
interaction (F/Fo: Intensity/Initial intensity). Black dots: experi-
mental data. White dots: fitted curve model for an interaction with a
dissociation constant (Kd) of approximately 4610
28 M. VirB7-
XAC2622_24–139_His has two tryptophans (W34 and W71) while
VirB9XAC2620_34–255 has one (W177). See Materials and Methods
for experimental details.
(TIF)
Figure S6
1H-
15N residual dipolar couplings (RDCs) of
VirB7XAC2622_24–139. Blue:
15N- VirB7XAC2622_24–139 alone; red:
15N- VirB7XAC2622_24–139 in complex with
14N-VirB9XAC2620_
154–255. The N-terminal region with largest RDC value differences
corresponds to the VirB9XAC2620_154–255 binding site in VirB7XAC
2622_24–139. The VirB7XAC2622_24–139 concentration was 250 mM
in both experiments, with the addition of a 40% excess of
VirB9XAC2620_154–255 in the case of the VirB7-VirB9 complex.
(TIF)
Figure S7 The interaction between VirB7XAC2622_24–139 and
VirB9XAC2620_154–255 does not affect the oligomerization of
VirB7XAC2622_24–139. The cross-peak positions of the same
15N-
VirB7XAC2622_24–139 residues shift in fast exchange upon dilution
both in the absence (left) and in the presence (right) of
14N-
VirB9XAC2620_154–255. VirB7XAC2622_24–139 or VirB7XAC2622_
24–139-VirB9XAC2620_154–255 complex concentrations: 800 mM
(cyan), 400 mM (green) and 200 mM (orange). The arrows indicate
protein dilutions from 800 to 200 mM.
(TIF)
Figure S8 The conformation of the VirB9XAC2620 C-terminal
domain changes significantly upon interacting with VirB7XAC2622.
15N-HSQC spectra of
15N-VirB9XAC2620_154–255 in the absence
(red) and in the presence (green) of
14N-VirB7XAC2622_24–46.
Spectra were collected at 40uC on a 600 MHz spectrometer
equipped with a cold probe.
(TIF)
Table S1 Oligonucleotides, plasmids and strains used in this
study.
(DOC)
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